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Synthesis and characterization of novel zinc
phthalocyanines as potential photosensitizers
for photodynamic therapy of cancers
S. Moeno,a R. W. M. Krause,*b E. A. Ermilov,c,d W. Kuzyniakc and M. Höpfnerc
Two novel zinc phthalocyanines (Pcs): tetramethyl tetrakis-2,(3)-[(4-methyl-2-pyridyloxy)phthalocyani-
nato] zinc(II) (4) and (the negatively charged form) tetrakis-2,(3)-[(3-carboxylicacid-6-sulfanylpyridine)-
phthalocyaninato] zinc(II) (5), water soluble by virtue of their ionic substituent groups were synthesized.
The spectroscopic properties of both compounds were determined and their photodynamic activities
were investigated in a human tumor cell model. In aqueous media the two peripherally substituted water
soluble Pcs are highly aggregated. The phototoxic activity of the two novel Pcs (Pc 4 and Pc 5; 0–20 µM)
was shown to be time- and dose-dependent in human pancreatic carcinoid BON cells, leading to a
reduction of tumor cells of >80% compared to the controls. The eﬀectiveness of the treatment appeared
to be attenuated by the aggregation of Pcs under aqueous conditions. Interestingly, even those cells
that were not immediately killed by the photoactivated photosensitizer seemed to be aﬀected by the
Pc photodynamic activity, as a single PDT induced long-lasting eﬀects on cell survival. Even 4 days after
PDT, the number of surviving cells did not re-increase or still dropped, as compared to control cells. The
underlying mechanism of this observation has to be deciphered in future investigations.
Introduction
In the past few decades, photodynamic therapy (PDT) has
emerged as a minimally invasive regimen for the treatment of
cancers.1–5 Today, PDT oﬀers an attractive new direction or
addition to conventional therapies for diseases including
skin lesions, age-related macular degeneration, and cancers
(bladder, breast, brain, esophagus, head/neck, lung, and skin).
Its therapeutic action is based on the generation of singlet
oxygen (1O2) and other reactive oxygen species (ROS) that are
formed upon light activation of the photosensitizer (PS) which
is taken up with higher aﬃnity in malignant than in non-
malignant cells. After photoexcitation, the excited PS transfers
its energy to molecular tissue oxygen to generate ROS, of
which singlet oxygen is assumed to be the key cytotoxic
species causing localized oxidative cell damage and death. In
spite of great advances, PDT is not yet an integral part of clini-
cal practice due to serious drawbacks of the few regulatory
approved PSs, and these include poor solubility in water.
Notably, tetrapyrroles such as porphyrins,6–8 chlorins9–12
and phthalocyanines (Pcs)13–15 are being used as photoactive
agents in PDT. It should be mentioned that Pcs have been
shown to be some of the most eﬃcient PSs to date16 since they
have strong absorption in the far red spectral region, demon-
strate high intersystem crossing (ISC) to the first excited triplet
state and a high eﬃciency of singlet oxygen generation. The
photophysical properties of Pcs can be tuned by rational modi-
fication of their structure.17 This tuning may be achieved
through the addition of substituent groups on the periphery of
the Pc macrocycle as well as complexing the ligand with
diﬀerent metal ions giving metallated Pcs (MPcs).17,18 The
photophysical properties of the latter are highly dependent on
the central metal ion employed.17
The suitability of Pcs for PDT is highly dependent on their
water-solubility. Thus, some of the highest eﬃciencies of
tumor targeting in photodynamic activity are achieved with
water soluble Pcs.19,20 In order to accomplish water solubility,
water solubilizing groups may be introduced onto the Pc on
the periphery and non-periphery of the macrocycle or even as
axial ligands for Pcs that have been complexed with multi-
valent central metal ions such as Si4+, Al3+ Ga3+ and In3+.21–23
The most common groups used for rendering Pcs water
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soluble include carboxy, sulfonate and phosphono groups.24–26
Quaternization may also be employed for Pcs bearing pyridino
substituents.27
This work reports on the synthesis (Scheme 1) and charac-
terization of new tetrakis-2,(3)-[(4-methyl-2-pyridyloxy)phthalo-
cyaninato] zinc(II) (3) and its water soluble quaternized
(positively charged) form tetramethyl tetrakis-2,(3)-[(4-methyl-
2-pyridyloxy)phthalocyaninato] zinc(II) (4) and (the water
soluble negatively charged form) tetrakis-2,(3)-[(3-carboxylic-
acid-6-sulfanylpyridine)phthalocyaninato] zinc(II) (5) phthalo-
cyanines and their photodynamic activity on human
pancreatic carcinoid BON cells.28
Experimental methods
Materials
N,N-Dimethyl formamide (DMF), 4-nitrophthalonitrile, 2-
hydroxy-4-methylpyridine, 6-mercaptopyridine-3-carboxylic
acid, ethanol, chloroform (CHCl3), dichloromethane (DCM),
tetrahydrofuran (THF) and acetone were obtained from Sigma
Aldrich. Bio-beads S-X1 were obtained from Bio-Rad. Ultra-
pure water was obtained from a Milli-Q Water System
(Millipore Corp, Bedford, MA, USA).
Phthalocyanine solutions
Stock solutions of the phthalocyanine complexes were
prepared in water and stored at 4 °C. The drugs were diluted in
fresh media before each experiment. In order to evaluate the
eﬀect of Pcs on the cells, the cells were incubated with either
control medium or medium containing increasing concen-
trations of the respective Pcs.
Cell line
The human pancreatic carcinoid cell line BON was cultured in
a 1 : 1 mixture of DMEM and HAM’s F-12 medium containing
10% of FCS (Biochrom, Berlin, Germany) and 1% L-glutamine.
Cells were maintained at 37 °C under a 5% CO2 humidified
atmosphere.28–30 Under these conditions, the doubling time of
BON cells was 34 ± 4 h. Incubation and subsequent experi-
ments were performed while the cells were in the log phase of
their growth.
Methods and instruments
IR data were obtained by using the Perkin-Elmer spectrum
2000 FTIR spectrometer. 1H NMR spectra were recorded using
a Bruker AMX 600 MHz spectrometer. Elemental analyses were
carried out on a Vario EL III MicroCube CHNS Analyzer. Mass
spectral data were collected using a Bruker AutoFLEX III Smart
beam TOF/TOF mass spectrometer. The instrument was oper-
ated in positive ion mode using an m/z range of 400–3000. The
voltages of the ion sources were set at 19 and 16.7 kV for ion
sources 1 and 2 respectively, while the lens was set at 8.50 kV.
The reflector 1 and 2 voltages were set at 21 and 9.7 kV respect-
ively. The spectra were acquired using dithranol as the MALDI
matrix, and a 354 nm Nd:YAG laser.
Steady-state absorption and fluorescence spectroscopies
The ground-state absorption spectra were recorded using a
commercial spectrophotometer Shimadzu UV-2501PC. Steady-
state fluorescence spectra were measured in 1 cm × 1 cm
quartz cells using a combination of a cw-xenon lamp (XBO
150) and a monochromator (Lot-Oriel, bandwidth 10 nm) for
excitation and a polychromator with a cooled CCD matrix as
the detector system (Lot-Oriel, Instaspec IV).
Picosecond transient absorption spectroscopy
The setup for pump–probe experiments with picosecond time
resolution was described previously.31 Briefly, to measure the
transient absorption spectra, a white light continuum was gen-
erated as a test beam in a cell with a D2O–H2O mixture using
intense 25 ps pulses from a Nd3+:YAG laser (PL 2143A, Ekspla)
at 1064 nm. Before passing through the sample, the conti-
nuum radiation was split to obtain a reference spectrum. The
transmitted as well as the reference beams were focused into
two optical fibers and were recorded simultaneously at
diﬀerent traces on a cooled CCD-matrix (Lot-Oriel, Instaspec IV).
Tunable radiation from an OPG/OPA (Ekspla PG 401/SH,
tuning range 200–2300 nm) pumped by the third harmonic of
the same laser was used as an excitation beam. The mechan-
ical delay line allowed the measurement of light-induced
changes of the absorption spectrum at diﬀerent delays up
to 15 ns after excitation. Analysis of experimental data was
performed using the compensation method.32
Scheme 1 Synthetic route for 4-(4-methyl-2-pyridyloxy)phthalonitrile
(1), 4-(3-carboxylicacid-6-sulfanylpyridine)phthalonitrile (2) and phthalo-
cyanines 3, 4 and 5 (where (i) pentanol, zinc acetate, DBU, heating at
160 °C and (ii) dimethyl sulfate and heating at 120 °C under an inert gas).
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Light source and irradiation
The radiation unit used a 100 W halogen lamp (HLX 64627,
Osram, Germany) as the light source. The spectral output of
the lamp ranged from 400 to 800 nm. To prevent infrared
irradiation, a heat-reflecting filter (Präzisions Glas & Optik,
Iserlohn, Germany) with a cutting-oﬀ band for λ ≥ 700 nm
was inserted into the optical path. The illuminated area
(11 × 14 cm) had an average power density of incident light
of 15 mW cm−2. The light energy dose was measured
using a P-9710 radiometer controlled by a silicon photocell
(RW-3703-2 radiometer) from Gigahertz-Optik (Munich,
Germany). The total light energy dose was calculated by inte-
grating the energy signal over the entire period of irradiation.
Cells were illuminated for 33 or 66 min to achieve a total light
dose of 30 or 60 J cm−2, respectively.5
Measurement of growth inhibition
PS induced phototoxicity as well as dark toxic eﬀects of the Pcs
were determined by crystal violet staining of phthalocyanine
(0–20 µM) treated BON cells after incubation and subsequent
light irradiation (phototoxicity) or without illumination (dark
toxicity). BON cells were seeded at a density of 5000 cells per
well into 96-well microtiter plates and incubated with
the zinc phthalocyanine photosensitizers for 6 and 12 h
periods respectively. After the incubation period had lapsed
the phthalocyanine medium solution was replaced with new
medium solution and the plates were irradiated for 33 or
66 min by using an incoherent white light source and they
were then incubated for 2 day (48 h) and 4 day (96 h) periods
respectively. Crystal violet staining was carried out as pre-
viously described.33,34 Cells were washed with phosphate
buﬀer solution (PBS) and fixed with 1% gluteraldehyde. Fol-
lowing this step, cells were washed once more with PBS and
then stained with 0.1% crystal violet. The unbound crystal
violet dye was removed by washing. The crystal violet that had
been absorbed onto the cells was solubilized with 0.2% Triton
X-100. After this, light extinction was analyzed at 570 nm using
an ELISA reader.
Synthetic procedures
Procedure for the synthesis of 4-(4-methyl-2-pyridyloxy)-
phthalonitrile (1). The reagents 2-hydroxy-4-methylpyridine
(1.08 g, 9.9 mmol) and 4-nitrophthalonitrile (1.7 g, 9.8 mmol)
were dissolved in DMF (30 ml) under argon. After stirring for
30 min at room temperature, finely ground anhydrous potass-
ium carbonate (2.8 g, 20 mmol) was added in portions for 4 h
with eﬃcient stirring. The reaction mixture was stirred under
an argon atmosphere at room temperature for 3 days. Then the
mixture was poured into 200 ml iced water, and the precipitate
was filtered oﬀ, washed with water and then dried. The crude
product was recrystallized from ethanol. Finally the pure
product was dried in a vacuum to give a light purple powder.
Yield: 1.6 g (68.67%). IR [(KBr) νmax/cm
−1]: 3185 (C–H), 2229
(CuN), 1656 (C–C), 1441, 1406 (CvC), 1360, 1279, 1206 (C–O–
C), 1494(CvN). 1H NMR (DMSO-d6); δ ppm: 8.36 (s, 1H, Ar–H),
8.29 (d, 1H, Ar–H), 8.16 (d, 1H, Ar–H), 7.63–7.68 (m, 1H,
pyridyl-H), 7.13 (d, 1H, pyridyl-H), 7.07 (d, 1H, pyridyl-H),
2.20 (s, 3H, pyridyl-H). MS m/z: Calc.: 235.14; found: 236.08
[M + H]+.
Procedure for the synthesis of 4-(3-carboxylicacid-6-sulfanyl-
pyridine)phthalonitrile (2). The synthesis of 2 was similar to
that of 1, except that 6-mercaptopyridine-3-carboxylic acid (2 g,
12 mmol) was employed instead of 2-hydroxy-4-methylpyri-
dine. The amount of 4-nitrophthalonitrile used was 2 g
(12 mmol). The quantity of anhydrous potassium carbonate
used was 3 g (21.0 mmol). The phthalonitrile was precipitated
out of the solution by addition of the DMF slurry to acetone.
Finally the pure product was dried in a vacuum to give a
brownish yellow solid. Yield: 1.3 g (38.46%). IR [(KBr) νmax/
cm−1]: 3301 (COOH), 3150 (C–H), 2240 (CuN), 1362, 1208
(C–S–C), 1656 (C–C), 1439, 1409 (CvC), 1497 (CvN). 1H NMR
(DMSO-d6); δ ppm: 8.87 (s, 1H, pyridyl carboxyl-H), 8.82 (s, 1H,
Ar–H), 7.94 (s, 1H, pyridyl-H), 7.89 (d, 1H, Ar–H), 7.78 (d, 1H,
Ar–H), 7.39 (d, 1H, pyridyl-H), 7.17 (d, 1H, pyridyl-H). MS m/z:
Calc.: 281.28; found: 282.04 [M + H]+.
Procedure for the synthesis of tetrakis-2,(3)-[(4-methyl-2-pyri-
dyloxy)phthalocyaninato] zinc(II) (3). A mixture of anhydrous
zinc(II) acetate (0.6 g, 2.8 mmol), 4-(4-methyl-2-pyridyloxy)
phthalonitrile (1) (0.22 g, 0.94 mmol), DBU (0.27 mL, 2 mmol)
and pentanol (25 mL) was stirred at 160 °C for 5 h under a
nitrogen atmosphere. After cooling, the solution was mixed
with n-hexane. The blue solid product was precipitated and
collected by filtration and washed with n-hexane. The crude
product was purified by passing through a silica gel column
using chloroform to elute the product. The eluted product was
then recrystallized from DMF using methanol. The product
was dried in the oven at 100 °C overnight. Yield: 100 mg
(42%). UV/vis (DMSO): λmax nm (log ε); 676 (5.02), 610 (4.30),
360 (4.50); IR (KBr): νmax/cm
−1; 3098, 2606 (C–H), 1659 (C–C),
1495 (CvN), 1439, 1410 (CvC), 1360, 1213 (C–O–C). 1H NMR
(400 MHz, DMSO-d6) δ ppm: 9.06–8.96 (m, 4H, Ar–H),
8.35–8.32 (m, 4H, pyridyl-H), 8.16–8.12 (m, 4H, pyridyl-H),
7.97–7.90 (m, 4H, pyridyl-H), 7.65 (d, 4H, Ar–H), 7.20–7.17
(m, 4H, Ar–H), 1.22 (s, 12H, pyridyl methyl-H). Calc. for
C56H36N12O4Zn·2CH3OH: C: 65.08, H: 4.14, N: 15.70. Found:
C: 64.17, H: 5.09, N: 12.5. MALDI-TOF-MS m/z: Calc.:
1006.35.41; found: 1007.38 [M + H]+.
(Quaternized) tetramethyl tetrakis-2,(3)-[(4-methyl-2-pyri-
dyloxy)phthalocyaninato] zinc(II) (4). Yield: 28 mg (56%). UV/
vis (DMSO): λmax nm (log ε); 675 (4.91), 612 (4.17), 343 (4.51);
IR (KBr): νmax/cm
−1; 3050, 2618, 2380 (C–H), 1658 (C–C), 1498
(CvN), 1440, 1409 (CvC), 1360, 1213 (C–O–C). 1H NMR
(400 MHz, DMSO-d6) δ ppm: 8.09 (bs, 4H, Ar–H), 7.96 (bs, 4H,
pyridyl-H), 7.86–7.81 (m, 4H, Ar–H), 7.52 (d, 4H, pyridyl-H),
7.29 (d, 4H, Ar–H), 7.22 (d, 4H, pyridyl-H), 1.62 (s, 12H, pyridyl
methyl-H), 1.28 (s, 12H, CH3). Calc. for C60H48N12O12S2Zn:
C: 57.26, H: 3.84, N: 13.35, S: 5.09. Found: C: 58.11, H: 4.85,
N: 19.62, S: 6.31. MALDI-TOF-MS m/z: Calc.: 1258.65; found:
1261.86 [M + 3H]3+.
Procedure for the synthesis of tetrakis-2,(3)-(3-carboxylic-
acid-6-sulfanylpyridine)phthalocyaninato zinc(II) (5). The syn-
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thesis of 5 was as outlined for 3, except that compound 2
(0.22 g, 0.77 mmol) instead of compound 1 was employed. The
amounts of the other reagents were as follows: anhydrous zinc
acetate (0.23 g, 1.13 mmol), dry pentanol (25 ml) and DBU
(0.25 ml, 0.16 mmol). A dark green product was obtained after
washing with ethanol. It was purified by multiple dissolutions
into 0.1 M sodium hydroxide solution and repeatedly precipi-
tating out using 20% HCl. The final precipitated product was
washed with methanol, acetone and chloroform. The product
was finally dried in the oven overnight at 90 °C. Yield: 30 mg
(30%). UV/vis (DMSO): λmax nm (log ε) 683 (5.08), 616 (4.32),
368 (4.53). IR spectrum (cm−1): 3350 (COOH), 3082, 2622
(Ar–CH), 1440, 1400 (CvC), 1657 (C–C), 1498 (CvN), 1361,
1250 (C–S–C). 1H NMR (DMSO-d6) δ: 8.35 (bs, 4H, pyridyl-H),
8.25–8.23 (m, 4H, Ar–H), 8.16–8.14 (m, 8H, pyridyl-H), 7.97 (s,
4H, pyridyl-H), 7.84 (s, 4H, Ar–H), 7.33–7.26 (m, 4H, Ar–H).
Calc. for C56H28N12S4O8Zn·2CHCl3: C: 48.74, H: 2.13, N: 11.76,
S: 8.90%. Found: C: 47.59, H: 3.16, N: 11.65, S: 8.09%. MS
(ES-MS) m/z: Calc.: 1190.58; Found: 1192.64 [M + 2H]2+.
Results and discussion
Characterization of complexes 3, 4 and 5
The new complexes 3, 4 and 5 were characterized using
UV-Vis, IR, NMR spectroscopies, MALDI-TOF mass spectro-
metry and elemental analysis. The analyses are all consistent
with that expected as shown in the Experimental section with
the exception of an elevated nitrogen content for the nitrogen
for the elemental of the quaternized complex 4. Complex 3
exhibited solubility in organic solvents such as CHCl3 and
DCM, DMF and DMSO while complexes 4 and 5 were soluble
in the latter two solvents and aqueous media.
The mass spectra of the Pcs were obtained by the relatively
soft ionization MALDI-TOF technique with the molecular ion
peaks observed at 1007.38 for 3, 1261.86 for 4 and 1192.64
for 5.
The 1H NMR spectra of the complexes 3, 4 and 5 show
complex patterns due to the mixed isomer character of the
tetra substituted MPc derivatives and perhaps also due to
aggregation. Complexes 3, 4 and 5 were found to be pure by
1H NMR with all the substituent protons and the ring protons
observed in their respective regions.
UV/Vis absorption and fluorescence spectroscopy
The newly synthesized complexes 3, 4 and 5 showed no signs
of aggregation in the respective absorption spectra in DMF
(shown in Fig. 1). However strong aggregation was observed
when the compounds were dissolved in water as evidenced by
the intense broadening of absorption bands compared to the
spectra of these compounds in DMF. Moreover, there is a
hypsochromic shift of corresponding Q-band maxima when
the samples are dissolved in water (from 676 to 632 nm for 3,
from 675 to 641 nm for 4 and from 683 to 643 nm for 5
respectively, see Table 1). It seems that aggregation for the
quaternized Pc 4 is not as intense compared to the two other
Pcs, since the observed broadening of its absorption Q-band is
lower than that for 3 and 5 when dissolved in water (see
Fig. 1).
It was not possible to detect any fluorescence signal for the
Pcs 3, 4 and 5 in water since their fluorescence intensities lie
below the signal-to-noise ratio of the steady-state fluorescence
setup employed for this study. This observation is due to
aggregation of the Pc molecules in aqueous solution (due to
the likely formation of non-fluorescent aggregates, where
fast and very eﬃcient radiationless deactivation of the
first excited singlet state follows photoexcitation of a Pc
chromophore).35–37
The situation is completely diﬀerent for the same Pcs when
dissolved in DMF (fluorescence spectra are shown in Fig. 2).
The fluorescence maximum is located at 687 nm for 3, at
686 nm for 4 and at 695 nm for 5, respectively (Table 1).
Picosecond transient absorption spectroscopy (ps-TAS)
In order to bring to light the dynamics of the excited state
population–depopulation, transient absorption experiments
with picosecond time resolution (ps-TAS) were carried out. As
readily seen from Fig. 3, the transient absorption (TA) spectra
Fig. 1 Normalized UV/Vis absorption spectra of 3 (a), 4 (b) and 5 (c) dis-
solved in DMF and in water. Comparison of the absorption spectra of
these Pcs in aqueous solution is given in (d).
Table 1 Absorption, emission, photophysical and ﬂuorescence lifetime
data
Complex Solvent Log ε
Q banda
λmax (nm)
Emission
λmax (nm) ΦISC τ (ns)
3 DMF 5.02 676 687 0.50 2.71 ± 0.15
4 DMF 4.91 675 686 0.51 2.93 ± 0.18
5 DMF 5.08 683 695 0.62 2.49 ± 0.17
aWhen dissolved in water, the Q-band maxima of the complexes
showed a hypsochromic shift in the following order: from 676 to
632 nm for 3, from 675 to 641 nm for 4 and from 683 to 643 nm for
5 respectively.
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of the Pcs dissolved in DMF have a strong negative signal with
a maximum around 680 nm which corresponds to the bleach-
ing of the ground state absorption. The recovery of the ground
state population after photoexcitation occurs mono-exponen-
tially with a characteristic time (τ) of 2.71 ± 0.15 ns (3), 2.93 ±
0.18 ns (4) and 2.49 ± 0.17 ns (5) respectively (results shown in
Table 1).
Furthermore, it was observed that even 15 ns after exci-
tation, a ground state bleaching signal still remained. This
means that excitation energy is partly stored in a long-lived
excited state, namely the first excited triplet state. It is well-
known that the lifetime of a triplet state is much longer com-
pared to the first excited singlet state (normally it lies in the
microsecond or even millisecond range) due to the fact that
the T1–S0 transition is spin-forbidden.
17,38 In DMF the ISC
S1 → T1 quantum yield was calculated to be 0.50, 0.51 and 0.62
for phthalocyanines 3, 4 and 5 respectively (see Table 1). It
should be emphasized that the ISC quantum yield correlates
with that of the singlet oxygen generation (as both normally
have very close values). The quantum yield for singlet oxygen
production is a very important parameter for the use of Pcs as
PSs in PDT of cancers.17,38,39 Since all Pcs under investigation
show appreciable ISC quantum yield, they could be considered
promising candidates for use as photosensitizers in PDT.
Unfortunately, the situation changed dramatically when the
samples were dissolved in water. It was not even possible to
measure the TA spectra of Pc 5, due to high scattering of the
excitation light on the aggregates. It was possible, however, to
carry out pump–probe experiments for the Pcs 3 and 4, and
the results are presented in Fig. 4.
The TA spectra for the Pc 3 in aqueous solution were very
noisy and also the intensity of its ground bleaching was quite
low. It seems that the depopulation of the first excited singlet
state occurs extremely fast and practically follows an excitation
pulse (25 ps, FWHM). The ISC quantum yield value was esti-
mated to be practically 0.
The change in optical density (ΔOD) signal of Pc 4 dis-
solved in water is much more pronounced compared to that of
compound 3, and this is expected as 4 is in the water soluble
quaternized form. Nevertheless, the ground state bleaching
decays very fast with a characteristic time of 25 ± 10 ps, and
the quantum eﬃciency of population of the first excited triplet
state via ISC was estimated to be only 2%. This 2% eﬃciency
Fig. 2 Normalized ﬂuorescence spectra of the Pcs 3, 4 and 5 dissolved
in DMF.
Fig. 3 Transient absorption spectra at diﬀerent delay times after exci-
tation (a, c, e) and ground state bleaching (mono-exponential ﬁt is
shown as a red line) (b, d, f ) of the phthalocyanines 3 (a, b), 4 (c, d ) and
5 (e, f ) dissolved in DMF.
Fig. 4 Transient absorption spectra (a, c) and ground state bleaching
(mono-exponential ﬁt is shown as a red line) (b, d ) of Pcs 3 (a, b) and 4
(c, d ) dissolved in water.
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of triplet state population is rather low and thus is less likely
to result in significant PDT eﬃciency.
In summary, it was found that Pcs 3, 4 and 5 have a very
high tendency to aggregate when dissolved in water. This
aggregation tendency in water results in a quenching of their
fluorescence as well as ISC quantum yields compared to the
corresponding results of the phthalocyanines when dissolved
in DMF.
In vitro determination of Pc-induced phototoxicity
The photodestructive potency of water soluble complexes 4
and 5 (high aggregation tendency in water) was investigated
in BON cells, which were used as a model cell line of human
pancreatic carcinoid tumors.30 Water soluble complexes were
targeted for synthesis and investigation in this work because
favorable and high eﬃciencies of tumor targeting in photo-
dynamic activity are achieved with the use of such Pcs. For
both compounds dark- and phototoxicity measurements were
carried out at concentrations ranging from 0 to 20 µM (Fig. 5).
BON cells were incubated with complexes 4 and 5 for 6 h and
12 h prior to illumination, which was performed with a light
dose of 30 or 60 J cm−2, respectively. Irradiation dose-depen-
dently decreased the cell numbers of BON cells pretreated with
either complex 4 or 5 compared to untreated controls (Fig. 5).
Non-photoactivated Pcs (0–20 μM) did not aﬀect cell prolifer-
ation of BON cells (figure not shown).
The IC50 value of Pc 5 phototoxicity (12 h Pc incubation)
calculated two days after PDT was found to be 5.7 ± 1.6 µM.
The Pc 5-induced cell number reduction on day 4 was not ade-
quate to allow for the calculation of its IC50 value. BON cells
showed maximal eﬀects with a decrease in cell number of
approximately 80% at complex 5 concentration of 10 µM and a
light dose of 60 J cm−2 (Fig. 5d). The fact that the number
of cells in complex 5 PDT treated samples did not markedly
re-increase even after 4 days indicated that there was no
appreciable re-proliferation, which is of particular interest for
a compound that is well-suited for PDT. It shows that even
those cells that were not immediately killed by the photoacti-
vated photosensitizer were nevertheless aﬀected by the PDT.
Whether the underlying mode of action involved is apoptosis,
necrosis, a stop or at least delay in cancer cell mitosis, or a
combination of these, this has to be deciphered in future
investigations; as the applied crystal violet-method does not
measure these events, but solely determines changes in the
cell number as compared to control cells.
Pc 4 showed lower phototoxicity compared to Pc 5 with the
result that the cell number reduction induced by Pc 4 was not
suﬃcient to allow for the calculation of its IC50 value. BON
cells showed reasonable eﬀects with a decrease in cell number
of approximately 50% at complex 4 concentration of 20 µM
and a light dose of 60 J cm−2 (Fig. 5b). It was also noted that
the number of cells in complex 4 PDT treated samples did not
show a considerable re-increase even after 4 days. The IC50
values obtained in this work were higher than those obtained
in work by other researchers using ZnPc and AlPc deriva-
tives.21,22 However, PDT conditions and especially illumination
(laser, wavelength, and light dose) are diﬀerent. Therefore, a
direct comparison of IC50 values measured here with those
found in the literature is not appropriate. In order to
estimate the eﬀectiveness of our Pcs, additional experiments
were conducted with the clinically approved photosensitizer
Photofrin (0–10 µM) using the same PDT conditions (6 h of
incubation and cell number detection at 48 h after PDT
with 30 or 60 J cm−2 irradiation doses). Photofrin-PDT dose-
dependently reduced the BON cell number by up to 85% (data
not shown) which is in the range of the cell number reduction
induced by PDT from the Pcs used in this work (>80% with
Pc 5).
The diﬀerences in photodynamic activity of the two com-
plexes 4 and 5 may be a result of diﬀerences in charge borne
by each complex. Complex 4 is tetra positively charged by
virtue of its being a quaternized nitrogen compound, while
complex 5 is negatively charged because of the ionizable car-
boxyl groups. These diﬀerences in charge borne by complexes
4 and 5 might possibly influence and favor the uptake of 5
over 4 thereby resulting in enhanced photodynamic activity of
complex 5. It seems that the cellular environment reduces the
probability of aggregation possibly leading to moderate gene-
ration of cytotoxic singlet oxygen upon photoexcitation of the
phthalocyanine chromophores. However, the cytotoxic
capacities of complexes in the cells might possibly be associ-
ated with the subcellular localization of the Pcs once taken
into the cell.40,41
Conclusions
Two water soluble novel Zn(II)Pc complexes 4 and 5 were syn-
thesized and in vitro studies were carried out to determine
their photodynamic activity. The two complexes did not
Fig. 5 Eﬀects of photoactivated Pcs on human cancer cells. BON cells
incubated for 6 h or 12 h with complex 4 (a, b) and complex 5 (c, d )
were irradiated with 30 or 60 J cm−2 light dose. Changes in the cell
number were determined by the crystal violet staining-method 48 and
96 h after PDT treatment. Cell number changes are shown as a percen-
tage of irradiated but Pc-untreated control cells, which were set at
100%. Data are given as mean values ± SEM of n = 4 independent
experiments.
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exhibit dark toxicity but led to phototoxic cell killing after light
activation. The Pcs 4 and 5 have shown moderate photo-
dynamic activity in in vitro experiments. Compound 5 demon-
strated even more pronounced phototoxic and growth
inhibitory eﬀects as compared to compound 4. This may be
due to a more favored cellular uptake of the tetra negatively
charged complex 5. Further investigations will have to clarify
the exact uptake mechanism and kinetic behavior of complex
5 in human tumor cells. As the photodestructive potency of
compound 5 is promising for novel approaches in PDT it
merits further elucidation.
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